TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 4 | 7 | 2 | 2 | 2 | 38 | 9 |
| P | %wins | 75 | 75 | 50 | 50 | 25 | 100 | 63 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/8/15 11:30 | 11/27/15 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Leventhal Mark S | PA | D | P.am | 22 | 1.55 | 0 | 14 | 2 | 882 | D | -24 | -10 | -5 | -13 | -15 | 9 | -8 | -4 | 7 | 14 | 11 | -4 | -3 | 50 | |
12/8/15 11:27 | 11/24/15 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Leventhal Mark S | PA | D | P.am | 46 | 1.30 | 0 | 36 | 4 | 868 | D | -24 | -10 | -5 | -13 | -15 | 9 | -8 | -4 | 7 | 14 | 11 | -4 | -3 | 50 | |
5/10/13 16:30 | 5/8/13 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Leventhal Mark S | PA | D | P.m | 16 | 1.60 | 0 | 10 | 2 | 450 | I | 62 | 58 | 1 | 1 | -5 | 5 | 10 | -1 | 1 | 1 | -1 | 3 | 17 | 25 | |
11/30/12 18:00 | 11/28/12 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Leventhal Mark S | PA | D | P.m | 231 | 1.54 | 0 | 150 | 52 | 440 | I | 9 | 20 | 44 | 52 | -5 | 1 | -5 | 15 | -1 | -2 | -15 | 13 | -2 | 26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |